Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy.
Saved in:
| Title: | Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy. |
|---|---|
| Authors: | AduQuaye, Marina1 (AUTHOR) maduquaye@cancercare.mb.ca, Dube, Sheen1,2 (AUTHOR) dubes@learners.sjr.mb.ca, Bashir, Bashir1 (AUTHOR) bbashir1@cancercare.mb.ca, Chowdhury, Amitava1 (AUTHOR) achowdhury@cancercare.mb.ca, Ahmed, Naseer1 (AUTHOR) nahmed2@cancercare.mb.ca, Leylek, Ahmet1 (AUTHOR) aleylek@cancercare.mb.ca, Kim, Julian1 (AUTHOR) jkim7@cancercare.mb.ca, Lambert, Pascal3 (AUTHOR) plambert@cancercare.mb.ca, Bucher, Oliver3 (AUTHOR) obucher@cancercare.mb.ca, Hunter, William1,4 (AUTHOR) whunter@cancercare.mb.ca, Sivananthan, Gokulan1,4 (AUTHOR) gsivananthan@cancercare.mb.ca, Koul, Rashmi1 (AUTHOR) rkoul@cancercare.mb.ca, Rathod, Shrinivas1 (AUTHOR) srathod@cancercare.mb.ca |
| Source: | Current Oncology. Feb2022, Vol. 29 Issue 1, p193-208. 16p. 4 Charts, 7 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11980052 |
|---|---|
| DOI: | 10.3390/curroncol29010019 |
